Susan M. Butler-Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan M. Butler-Wu has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
Paul Holtom
Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, CA
4 shared publicationsTam T. Van
Department of Pathology, Harbor-UCLA Medical Center, Torrance, California, USA
3 shared publications- Aditya Jones
Division of Infectious Diseases, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California, USA
2 shared publications Allen C. Bateman
Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA
2 shared publications- Audrey N. Schuetz
Department of Laboratory Medicine and Pathology, Mayo Clinic
2 shared publications - Brian James Werth
Department of Pharmacy, School of Pharmacy, University of Washington , 1959 NE Pacific St., HSB H-375, Box 357630, Seattle, WA 98195-7630
2 shared publications
Latest Publications
- Open Access
- 22 July 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (7) , 006844
‘What’s in a name? Fit-for-purpose bacterial nomenclature’: meeting report
Rapid and economical DNA sequencing has resulted in a revolution in phylogenomics. The impact of changes in nomenclature can be perceived as an absolute necessity of scientific rigour, coupled with the slight inconvenience of needing to re-learn names. In relation to practical aspects of microbiology, for example, infectious disease diagnosis, there may, however, be potential dangers. Historically, prokaryote classification has been based on multiple metabolic, physiological, biochemical and descriptive characteristics combined with the environmental source. Whole-genome sequence data have transformed our ability to determine evolutionary relationships. In addition, metagenomic and metataxonomic sequencing have resulted in the discovery of novel microbes, many of which are yet to be cultured. As a result, occasional name changes and additional prokaryote discoveries have accelerated at an unprecedented pace. Herein is a report of a Microbiology Society supported meeting of representatives of the communities of specialist taxonomists, phylogeneticists and applied microbiologists. Discussion included: recent advances in phylogenomics and the potential impact of nomenclature change on practical microbiology, e.g. plant pathology, food security, industrial microbiology, clinical microbiology and infectious diseases; the need, or lack thereof, for wider consideration and consultation prior to nomenclature change proposals which impact on practical microbiology; the application of the intricate and highly necessary rules of prokaryote nomenclature, which sometimes appear unfathomable to the non-specialist; and genome-based phylogenomics and the relationship with the International Code of Nomenclature of Prokaryotes. The meeting resulted in the formation of the Ad Hoc Committee for Mitigating Changes in Prokaryotic Nomenclature under the auspices of the International Committee on Systematics for Prokaryotes.
- 22 July 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (7) , 006844
Open Access‘What’s in a name? Fit-for-purpose bacterial nomenclature’: meeting report
Rapid and economical DNA sequencing has resulted in a revolution in phylogenomics. The impact of changes in nomenclature can be perceived as an absolute necessity of scientific rigour, coupled with the slight inconvenience of needing to re-learn names. In relation to practical aspects of microbiology, for example, infectious disease diagnosis, there may, however, be potential dangers. Historically, prokaryote classification has been based on multiple metabolic, physiological, biochemical and descriptive characteristics combined with the environmental source. Whole-genome sequence data have transformed our ability to determine evolutionary relationships. In addition, metagenomic and metataxonomic sequencing have resulted in the discovery of novel microbes, many of which are yet to be cultured. As a result, occasional name changes and additional prokaryote discoveries have accelerated at an unprecedented pace. Herein is a report of a Microbiology Society supported meeting of representatives of the communities of specialist taxonomists, phylogeneticists and applied microbiologists. Discussion included: recent advances in phylogenomics and the potential impact of nomenclature change on practical microbiology, e.g. plant pathology, food security, industrial microbiology, clinical microbiology and infectious diseases; the need, or lack thereof, for wider consideration and consultation prior to nomenclature change proposals which impact on practical microbiology; the application of the intricate and highly necessary rules of prokaryote nomenclature, which sometimes appear unfathomable to the non-specialist; and genome-based phylogenomics and the relationship with the International Code of Nomenclature of Prokaryotes. The meeting resulted in the formation of the Ad Hoc Committee for Mitigating Changes in Prokaryotic Nomenclature under the auspices of the International Committee on Systematics for Prokaryotes.
- Open Access
- 21 November 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (11) , e0035723
Multicenter evaluation of the BIOFIRE Joint Infection Panel for the detection of bacteria, yeast, and AMR genes in synovial fluid samples
The bioMérieux BIOFIRE Joint Infection (JI) Panel is a multiplex in vitro diagnostic test for the simultaneous and rapid (~1 h) detection of 39 potential pathogens and antimicrobial resistance (AMR) genes directly from synovial fluid (SF) samples. Thirty-one species or groups of microorganisms are included in the kit, as well as several AMR genes. This study, performed to evaluate the BIOFIRE JI Panel for regulatory clearance, provides data from a multicenter evaluation of 1,544 prospectively collected residual SF samples with performance compared to standard-of-care (SOC) culture for organisms or polymerase chain reaction (PCR) and sequencing for AMR genes. The BIOFIRE JI Panel demonstrated a sensitivity of 90.9% or greater for all but six organisms and a positive percent agreement (PPA) of 100% for all AMR genes. The BIOFIRE JI Panel demonstrated a specificity of 98.5% or greater for detection of all organisms and a negative percent agreement (NPA) of 95.7% or greater for all AMR genes. The BIOFIRE JI Panel provides an improvement over SOC culture, with a substantially shorter time to result for both organisms and AMR genes with excellent sensitivity/PPA and specificity/NPA, and is anticipated to provide timely and actionable diagnostic information for joint infections in a variety of clinical scenarios.
- 21 November 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (11) , e0035723
Open AccessMulticenter evaluation of the BIOFIRE Joint Infection Panel for the detection of bacteria, yeast, and AMR genes in synovial fluid samples
The bioMérieux BIOFIRE Joint Infection (JI) Panel is a multiplex in vitro diagnostic test for the simultaneous and rapid (~1 h) detection of 39 potential pathogens and antimicrobial resistance (AMR) genes directly from synovial fluid (SF) samples. Thirty-one species or groups of microorganisms are included in the kit, as well as several AMR genes. This study, performed to evaluate the BIOFIRE JI Panel for regulatory clearance, provides data from a multicenter evaluation of 1,544 prospectively collected residual SF samples with performance compared to standard-of-care (SOC) culture for organisms or polymerase chain reaction (PCR) and sequencing for AMR genes. The BIOFIRE JI Panel demonstrated a sensitivity of 90.9% or greater for all but six organisms and a positive percent agreement (PPA) of 100% for all AMR genes. The BIOFIRE JI Panel demonstrated a specificity of 98.5% or greater for detection of all organisms and a negative percent agreement (NPA) of 95.7% or greater for all AMR genes. The BIOFIRE JI Panel provides an improvement over SOC culture, with a substantially shorter time to result for both organisms and AMR genes with excellent sensitivity/PPA and specificity/NPA, and is anticipated to provide timely and actionable diagnostic information for joint infections in a variety of clinical scenarios.
- 20 April 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (4) , e0171222
Comparative Evaluation of Current Biochemical-, Sequencing-, and Proteomic-Based Identification Methods for the Streptococcus bovis Group
The Streptococcus bovis group (previously group D streptococci) consists of seven distinct species and subspecies. Definitive identification within the group is important, as certain organisms have been associated with gastrointestinal carcinoma, bacteremia, infective endocarditis, meningitis, biliary tract disease, and carcinoma, among others.
- 20 April 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (4) , e0171222
Comparative Evaluation of Current Biochemical-, Sequencing-, and Proteomic-Based Identification Methods for the Streptococcus bovis Group
The Streptococcus bovis group (previously group D streptococci) consists of seven distinct species and subspecies. Definitive identification within the group is important, as certain organisms have been associated with gastrointestinal carcinoma, bacteremia, infective endocarditis, meningitis, biliary tract disease, and carcinoma, among others.
- 26 January 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (1) , e0173222
Point-Counterpoint: What’s in a Name? Clinical Microbiology Laboratories Should Use Nomenclature Based on Current Taxonomy
The mnemonic SPICE ( Serratia , Pseudomonas , indole-positive Proteus , Citrobacter , and Enterobacter ) has served as a reminder to consider when a Gram-negative organism may carry a chromosomal copy of bla ampC , with the associated risk of developing resistance to first-, second-, and third-generation cephalosporins. However, in 2017, there was a well-founded proposal to rename Enterobacter aerogenes to Klebsiella aerogenes , based on whole-genome sequencing (WGS), and the SPICE mnemonic lost its relevance.
- 26 January 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (1) , e0173222
Point-Counterpoint: What’s in a Name? Clinical Microbiology Laboratories Should Use Nomenclature Based on Current Taxonomy
The mnemonic SPICE ( Serratia , Pseudomonas , indole-positive Proteus , Citrobacter , and Enterobacter ) has served as a reminder to consider when a Gram-negative organism may carry a chromosomal copy of bla ampC , with the associated risk of developing resistance to first-, second-, and third-generation cephalosporins. However, in 2017, there was a well-founded proposal to rename Enterobacter aerogenes to Klebsiella aerogenes , based on whole-genome sequencing (WGS), and the SPICE mnemonic lost its relevance.
- 20 July 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (7) , e0249521
Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates
Antistaphylococcal penicillins and cefazolin remain the primary treatments for infections with methicillin-susceptible Staphylococcus aureus (MSSA). The cefazolin inoculum effect (CzIE) causes the cefazolin MIC to be elevated in proportion to the number of bacteria in the inoculum.
- 20 July 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (7) , e0249521
Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates
Antistaphylococcal penicillins and cefazolin remain the primary treatments for infections with methicillin-susceptible Staphylococcus aureus (MSSA). The cefazolin inoculum effect (CzIE) causes the cefazolin MIC to be elevated in proportion to the number of bacteria in the inoculum.
- 21 June 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (6) , e0261420
New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides
The long-acting lipoglycopeptides (LGPs) dalbavancin and oritavancin are semisynthetic antimicrobials with broad and potent activity against Gram-positive bacterial pathogens. While they are approved by the Food and Drug Administration for acute bacterial skin and soft tissue infections, their pharmacological properties suggest a potential role of these agents for the treatment of deep-seated and severe infections, such as bloodstream and bone and joint infections.
- 21 June 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (6) , e0261420
New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides
The long-acting lipoglycopeptides (LGPs) dalbavancin and oritavancin are semisynthetic antimicrobials with broad and potent activity against Gram-positive bacterial pathogens. While they are approved by the Food and Drug Administration for acute bacterial skin and soft tissue infections, their pharmacological properties suggest a potential role of these agents for the treatment of deep-seated and severe infections, such as bloodstream and bone and joint infections.
- 8 April 2022
- Published by Elsevier in Journal of Clinical Virology
- Vol. 150-151, 105153
SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases
- 8 April 2022
- Published by Elsevier in Journal of Clinical Virology
- Vol. 150-151, 105153
SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases
- 4 March 2022
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 42 (2) , 203-222
Rapid Antigen Assays for SARS-CoV-2
- 4 March 2022
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 42 (2) , 203-222
Rapid Antigen Assays for SARS-CoV-2
- 16 February 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (2) , e0080621
Answer to February 2022 Photo Quiz
The isolate was identified as Kodamaea ohmeri (99% confidence value) by Vitek MS (v3.2). Whereas Candida tropicalis produces blue colonies on most chromogenic agars, the combination of pink/purple-to-blue colonies is a hallmark of K. ohmeri. Colonies become fully blue after approximately 1 week of incubation (1). While Malassezia furfur was initially considered due to the patient’s TPN, it grows poorly on solid media in the absence of lipid supplementation. Phenotypic methods (e.g., API ID32C) are unreliable for the identification of K. ohmeri, with only 46.8% of isolates correctly identified in one study (1). In contrast, MALDI-ToF-MS shows high accuracy for this organism with correct species-level identification rates of 96.8% for both Bruker Biotyper and Vitek MS (2).
- 16 February 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (2) , e0080621
Answer to February 2022 Photo Quiz
The isolate was identified as Kodamaea ohmeri (99% confidence value) by Vitek MS (v3.2). Whereas Candida tropicalis produces blue colonies on most chromogenic agars, the combination of pink/purple-to-blue colonies is a hallmark of K. ohmeri. Colonies become fully blue after approximately 1 week of incubation (1). While Malassezia furfur was initially considered due to the patient’s TPN, it grows poorly on solid media in the absence of lipid supplementation. Phenotypic methods (e.g., API ID32C) are unreliable for the identification of K. ohmeri, with only 46.8% of isolates correctly identified in one study (1). In contrast, MALDI-ToF-MS shows high accuracy for this organism with correct species-level identification rates of 96.8% for both Bruker Biotyper and Vitek MS (2).
- 16 February 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (2) , e0080521
Photo Quiz: Color Me Twice
A 62-year-old male presented to our hospital from oncology clinic after he was found to be hypotensive and tachycardic. In clinic, he complained of weakness, dizziness, brown/yellow emesis, and an inability to keep water down for 1 week. His past medical history was significant for tobacco use and invasive squamous cell carcinoma of the esophagus.
- 16 February 2022
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (2) , e0080521
Photo Quiz: Color Me Twice
A 62-year-old male presented to our hospital from oncology clinic after he was found to be hypotensive and tachycardic. In clinic, he complained of weakness, dizziness, brown/yellow emesis, and an inability to keep water down for 1 week. His past medical history was significant for tobacco use and invasive squamous cell carcinoma of the esophagus.